Sylhet M.A.G.Osmani Medical College Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2012
NCT02650869
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Consultant, Medicine, Sylhet M.A.G.Osmani Medical Collge, Sylhet, Bangladesh | Professor and Head, Department of Paediatrics, Sylhet M.A.G.Osmani Medical College | Sylhet M.A.G.Osmani Medical College

Active Ingredients

Drugs in Phase 3 Trials (3)

albuterol (proventil) (1 trial)

autologous microbiome (1 trial)

human milk (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Enterocolitis (Phase 3)

Enterocolitis, Necrotizing (Phase 3)

Organophosphate Poisoning (Phase 3)

Poisoning (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3